Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development ofatherosclerosis

Citation
M. Kaplan et al., Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development ofatherosclerosis, J NUTR, 131(8), 2001, pp. 2082-2089
Citations number
49
Categorie Soggetti
Food Science/Nutrition","Endocrinology, Nutrition & Metabolism
Journal title
JOURNAL OF NUTRITION
ISSN journal
00223166 → ACNP
Volume
131
Issue
8
Year of publication
2001
Pages
2082 - 2089
Database
ISI
SICI code
0022-3166(200108)131:8<2082:PJSTAM>2.0.ZU;2-M
Abstract
Inhibition of lipid peroxidation contributes to the attenuation of macropha ge cholesterol accumulation, foam-cell formation and atherosclerosis. Evide nce suggests that nutritional antioxidants such as pomegranate juice (PJ) c an contribute to the reduction of oxidative stress and atherogenesis. The g oals of the present study were to determine whether such beneficial effects of PJ exist when supplemented to apolipoprotein E-deficient (E degrees) mi ce with advanced atherosclerosis and to analyze the antiatherosclerotic act ivity of a tannin-fraction isolated from PJ. Mice (4-mo-old) were supplemen ted with PJ in their drinking water for 2 mo and compared with age-matched placebo-treated mice, as well as to young (4-mo-old) control mice, for thei r mouse peritoneal macrophage (MPM) oxidative state, cholesterol flux and m ice atherosclerotic lesion size. PJ supplementation reduced each of the pro atherogenic variables determined in the present study compared with age-mat ched placebo-treated mice. It significantly induced serum paraoxonase activ ity and reduced MPM lipid peroxide content compared with placebo-treated mi ce and control mice. PJ administration to E degrees mice significantly redu ced the oxidized (Ox)-LDL MPM uptake by 31% and MPM cholesterol esterificat ion and increased macrophage cholesterol eff lux by 39% compared with age-m atched, placebo-treated mice. PJ consumption reduced macrophage Ox-LDL upta ke and cholesterol esterification to levels lower than those in 4-mo-old, u nsupplemented controls. PJ supplementation to E degrees mice with advanced atherosclerosis reduced the lesion size by 17% compared with placebo-treate d mice. In a separate study, supplementation of young (2-mo-old) E degrees mice for 2 mo with a tannin fraction isolated from PJ reduced their atheros clerotic lesion size, paralleled by reduced plasma lipid peroxidation and d ecreased Ox-LDL MPM uptake. PJ supplementation to mice with advanced athero sclerosis reduced their macrophage oxidative stress, their macrophage chole sterol flux and even attenuated the development of atherosclerosis. Moreove r, a tannin-fraction isolated from PJ had a significant antiatherosclerotic activity.